HAL Allergy B.V. (Ltd) is a main European manufacturer of allergy vaccines and diagnostics. From our Haarlem headquarters (HQ) in the Netherlands we steer and control all our international activities. Our products are being distributed via several distributors and own subsidiaries for Germany, Spain, Italy, Poland, Austria and the Benelux. Currently Hal Allergy employs over 250 people throughout Europe with more than 140 situated in the Netherlands. The R&D, Production, Quality Control, Clinical Affairs, Regulatory Affairs and administrative departments are all situated in the Haarlem location, allowing for strong synergies between the manufacturing and commercial processes. To further strengthen our market capabilities we have begun construction on a new manufacturing and office site at the Bio Science Park in Leiden. The new site will be fully operational in 2009.
HAL Allergy is a growing, dynamic biopharmaceutical company with a strong culture rooted in entrepreneurial spirit. Since our establishment in 1959 we have maintained a family atmosphere while also strongly pursuing a professional and sustained growth path. This combination of familiar culture and entrepreneurial flair have laid the foundation for a fun, challenging and rewarding environment.
2011 KT Haarlem